Literature DB >> 15018832

AMPA receptor modulators as cognitive enhancers.

Gary Lynch1.   

Abstract

AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid)-type glutamate receptors mediate fast excitatory transmission throughout the central nervous system. Positive modulation of these receptors can potentially enhance cognition by, firstly, offsetting losses of glutamatergic synapses; secondly, promoting synaptic plasticity; and thirdly, increasing the production of trophic factors. The advent of small molecules that selectively enhance AMPA receptors in the brain made it possible to test these hypotheses. Preclinical experiments indicate that the compounds accelerate the encoding of memory and have positive effects on models of cognitive dysfunction. Initial results with human subjects are also positive. AMPA receptor modulators thus represent an entirely new approach to cognitive enhancement and the treatment of diverse brain disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15018832     DOI: 10.1016/j.coph.2003.09.009

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  38 in total

1.  Synaptic evidence for the efficacy of spaced learning.

Authors:  Enikö A Kramár; Alex H Babayan; Cristin F Gavin; Conor D Cox; Matiar Jafari; Christine M Gall; Gavin Rumbaugh; Gary Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

2.  The effects of huperzine A and IDRA 21 on visual recognition memory in young macaques.

Authors:  Ludise Malkova; Alan P Kozikowski; Karen Gale
Journal:  Neuropharmacology       Date:  2010-12-23       Impact factor: 5.250

Review 3.  Ionotropic and metabotropic glutamate receptor structure and pharmacology.

Authors:  James N C Kew; John A Kemp
Journal:  Psychopharmacology (Berl)       Date:  2005-02-25       Impact factor: 4.530

Review 4.  How astrocytes feed hungry neurons.

Authors:  Luc Pellerin
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

Review 5.  Phosphorylation of AMPA receptors: mechanisms and synaptic plasticity.

Authors:  John Q Wang; Anish Arora; Lu Yang; Nikhil K Parelkar; Guochi Zhang; Xianyu Liu; Eun Sang Choe; Limin Mao
Journal:  Mol Neurobiol       Date:  2005-12       Impact factor: 5.590

6.  Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6/2 mice.

Authors:  Danielle A Simmons; Rishi A Mehta; Julie C Lauterborn; Christine M Gall; Gary Lynch
Journal:  Neurobiol Dis       Date:  2010-10-23       Impact factor: 5.996

Review 7.  Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders.

Authors:  Stefano Marenco; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

8.  Activation of 5-HT(6) receptors facilitates attentional set shifting.

Authors:  Katherine E Burnham; Mark G Baxter; John R Bainton; Eric Southam; Lee A Dawson; David M Bannerman; Trevor Sharp
Journal:  Psychopharmacology (Berl)       Date:  2009-11-10       Impact factor: 4.530

Review 9.  Multiple cellular cascades participate in long-term potentiation and in hippocampus-dependent learning.

Authors:  Michel Baudry; Guoqi Zhu; Yan Liu; Yubin Wang; Victor Briz; Xiaoning Bi
Journal:  Brain Res       Date:  2014-12-04       Impact factor: 3.252

10.  Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease.

Authors:  Paula T Trzepacz; Jeffrey Cummings; Thomas Konechnik; Tammy D Forrester; Curtis Chang; Ellen B Dennehy; Brian A Willis; Catherine Shuler; Linda B Tabas; Constantine Lyketsos
Journal:  Int Psychogeriatr       Date:  2012-12-21       Impact factor: 3.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.